Method Development and Optimization

This work will establish new and better ways to measure the effects of psychedelics including behavioral measures (e.g., creative thinking, rumination, empathy), biological and neural measures (e.g., brain activity) to inform clinical trial design.

Coming Soon: Stay tuned for upcoming projects focused on method development and optimization.

Reach out, and we’ll get back to you.

Name(Required)

Email(Required)

Organization Name

Message(Required)

Newsletter

I would like to subscribe to ADAPT’s mailing list.